Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
The Inducement Grant has an exercise price per share that is equal to the closing price of Viridian's common stock on the Grant Date. The Inducement Grant will vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the employee's start date, and thereafter the remainder of the shares vest in 36 equal monthly installments, subject to the employee's continued employment with Viridian through the applicable vesting dates.
About Viridian Therapeutics
Viridian is a biopharmaceutical company focused on discovering, developing and commercializing potential best-in-class medicines for patients with serious and rare diseases. Viridian's expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.
Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting a pivotal program for veligrotug (VRDN-001), including two global phase 3 clinical trials (THRIVE and THRIVE-2), to evaluate its efficacy and safety in patients with active and chronic TED. Both THRIVE and THRIVE-2 reported positive topline data, meeting all the primary and secondary endpoints of each study. Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2, to evaluate the efficacy and safety of VRDN-003 in patients with active and chronic TED.
In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.
Viridian is based in Waltham, Massachusetts. For more information, please visit www.viridiantherapeutics.com. Follow Viridian on LinkedIn and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Apple Inc. (AAPL): People Are Tired Of The Stock Buybacks, Says Jim Cramer
We recently published . Apple Inc. (NASDAQ:AAPL) is one of the stocks Jim Cramer recently discussed. Cramer continues to be one of Apple Inc. (NASDAQ:AAPL)'s strongest proponents even though the firm's shares have lost 12.6% year-to-date. The stock has struggled due to trade tensions between the US and China that have threatened to disrupt the supply chain, the firm's struggle to convince the market about its presence in the AI market, and concerns about slow iPhone sales. However, the CNBC host believes that Apple Inc. (NASDAQ:AAPL) will maintain its stature as long as the firm holds its high-end smartphone market share. This time around, he criticized Apple Inc. (NASDAQ:AAPL)'s stock buybacks and deemed them inadequate: '[On reports of Apple reportedly looking to rely on third party AI] Look at how the stock reacted. Because people are tired of Apple just saying, you know what we're gonna do, we're gonna buy back stock until we get something better. No. I mean that's not what you can do anymore. A wide view of an Apple store, showing the range of products the company offers. Cramer commented on Apple Inc. (NASDAQ:AAPL)'s woes in detail recently. Here is what he said: '. . .Apple, which cannot get out of its own way. And I think probably could go down to 25 times earnings. Which is a substantial decline. Apple's a share donor. It's a share donor. '[On why Apple stock should be bought] No I'm not going to because I think the multiple's too high. While we acknowledge the potential of AAPL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
We've Witnessed U.S. Money Supply Make History on Both Ends of the Spectrum -- Including a First Since the Great Depression -- and It Foreshadows a Big-Time Move in Stocks
Heightened volatility often encourages investors to seek out events and data points that strongly correlate with moves higher or lower in the Dow, S&P 500, and Nasdaq Composite throughout history. Changes to U.S. money supply that haven't been observed in 90 to 155 years point to wild stock market vacillations persisting. Thankfully, history is a pendulum that swings disproportionately in both directions and has a knack for rewarding patience. 10 stocks we like better than S&P 500 Index › For more than a century, Wall Street has been a stomping ground for wealth creation. No other asset class has come particularly close to matching the annualized return of stocks spanning 100 years. However, this doesn't mean stocks move higher in a straight line. Volatility is the price investors pay for admission to the world's greatest wealth creator -- and 2025 has been chock-full of volatility. During a one-week stretch in April, the ageless Dow Jones Industrial Average (DJINDICES: ^DJI) and broad-based S&P 500 (SNPINDEX: ^GSPC) dipped into correction territory, while the Nasdaq Composite (NASDAQINDEX: ^IXIC) entered a bear market for the first time in three years. This was followed days later by all three indexes recording their largest single-day point gains since their respective inceptions. When the market vacillates wildly, it's common for investors to seek out clues that might tell them which direction stocks will head next. These clues come in the form of events and data points that have previously correlated with sizable moves higher or lower in one or more of Wall Street's major stock indexes. Though no event or data point can guarantee what's to come, some of these tools have remarkably strong track records of forecasting future returns. One metric, which has made history on both ends of the spectrum over the last couple of years, is currently foreshadowing a big-time move in stocks. While there are a number of telling metrics, events, and indicators, such as the stock market entering 2025 at one of its priciest valuations dating back 154 years, perhaps the most eyebrow-raising of them all is U.S. money supply. Among the numerous measures of money supply, M1 and M2 tend to garner the most attention. The former measures all cash and coins in circulation, as well as demand deposits in a checking account. In other words, it's capital that can be spent immediately. Meanwhile, M2 takes everything in M1 and adds in savings accounts, money market accounts, and certificates of deposit (CDs) below $100,000. This is still money that can be spent, but it requires more effort to do so. It's this money supply measure that's been all over the map and made history at opposite ends of the spectrum this decade. Normally, M2 money supply moves up and to the right. This is to say that, with very few exceptions, money supply has been steadily increasing over time. However, these rare exceptions have been doozies. The post you see above on X (formerly Twitter) comes from Reventure App CEO Nick Gerli. Even though it's more than two years old and the right side of the chart is now outdated -- I'll touch on this in greater detail in a moment -- it demonstrates one of the more intriguing correlations we've witnessed over the last 155 years. Prior to this decade, there had only been four instances where M2 money supply declined by at least 2% on a year-over-year basis: 1878, 1893, 1921, and 1931-1933. All four of these periods respectively correlate with economic depressions for the U.S. economy, as well as double-digit unemployment rates. Between April 2022 and October 2023, U.S. M2 money supply contracted by more than $1 trillion, equating to a 4.76% peak-to-trough decline. It represented the first time since the Great Depression that M2 fell by at least 2% year over year, as well as more than 2% on a peak-to-trough basis. Admittedly, things are quite different today than they were during the prior four occurrences where M2 declined by more than 2% on a year-over-year basis. For instance, the Federal Reserve didn't exist in 1878 and 1893. Further, monetary policy and fiscal policy know-how are far greater today than they were in the 1920s or during the Great Depression. But we've also witnessed money supply make history in the other direction. For starters, the latest update from the Board of Governors of the Federal Reserve System shows M2 hit an all-time high of $21.942 trillion in May 2025. It's erased the 4.76% peak-to-trough decline from April 2022 to October 2023 in its entirety (and then some!). Steadily climbing money supply is typically something that's observed when the U.S. economy is healthy and expanding, which is often good news for the stock market. Furthermore, M2 expanded by more than 26% on a year-over-year basis during the height of the COVID-19 pandemic due to fiscal stimulus. When back-tested to 1870, this is, by far, the quickest expansion of money supply in America's history. Thus, the outsized drop in M2 from April 2022 to October 2023 might have been nothing more than a benign mean reversion following a never-before-seen jump in money supply. Regardless of which historical M2 money supply moment shines brightest, all point to heightened volatility for the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite. Though wild gyrations in Wall Street's major stock indexes can, at times, be scary or tug on the heartstrings of investors, history has demonstrated a knack for rewarding those who exercise patience and perspective, and have an optimistic view on the U.S. economy and stock market. A perfect example of history rewarding optimists can be seen when examining U.S. economic cycles. On one hand, recessions are perfectly normal, healthy, and inevitable. No amount of fiscal or monetary policy maneuvering can stop economic slowdowns or downturns from taking shape sometimes. But the one prevailing theme of recessions is their rapid resolution. The average U.S. recession since the end of World War II has resolved in 10 months, and none have lasted longer than 18 months. In comparison, the average period of economic growth over the last eight decades clocks in at around five years and includes two periods of expansion that surpassed the 10-year mark. With corporate America enjoying far more time in the sun than under the gray clouds of a recession, it's no surprise that stocks have performed so well over extended periods. This leads to the next point: the disproportionate nature of bull and bear market cycles on Wall Street. In June 2023, shortly after the S&P 500 had entered its current bull market, Bespoke Investment Group published a data set on X (formerly Twitter) comparing the calendar-day length of every S&P 500 bull and bear market dating back to the start of the Great Depression. The 27 S&P 500 bear markets that occurred over the nearly 94 years examined stuck around for an average of just 286 calendar days, with the longest bear market enduring only 630 calendar days. Meanwhile, the typical S&P 500 bull market from September 1929 through June 2023 lasted 1,011 calendar days. Also, if the current bull market is extrapolated to present day, more than half of the 27 S&P 500 bull markets (14 out of 27) have stuck around longer than the lengthiest bear market. Regardless of the near-term volatility that (presumably) awaits Wall Street, history has shown time and again that investors who exercise patience and allow time to work its magic are handsomely rewarded. Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Sean Williams has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. We've Witnessed U.S. Money Supply Make History on Both Ends of the Spectrum -- Including a First Since the Great Depression -- and It Foreshadows a Big-Time Move in Stocks was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Tesla, Inc. (TSLA): Some People Are 'Gleeful' About Bad Car Sales, Reveals Jim Cramer
We recently published . Tesla, Inc. (NASDAQ:TSLA) is one of the stocks Jim Cramer recently discussed. Cramer discusses Tesla, Inc. (NASDAQ:TSLA) in nearly every morning appearance. This is partly due to the firm's CEO Elon Musk, whose recent back-and-forth with President Trump has caught media attention. After their first bout last month, Cramer wondered whether Tesla, Inc. (NASDAQ:TSLA) could maintain stable stock performance if Trump was displeased with Musk. Cramer also agrees with Musk on the fact that the firm's narrative will be determined by self-driving and humanoid robots instead of vehicle deliveries. In this show, he commented on Tesla, Inc. (NASDAQ:TSLA)'s share performance after Trump and Musk disagreed on the former's legislative efforts: '. . .this is the first time that I've seen this stock get crushed because the President did say that the subsidies, he's [Musk] the most subsidized person in America, alluded to maybe a trip to South Africa. . . Cramer continued to discuss Musk and Trump later in the day on Mad Money: 'Tesla, total dice roll. We have no idea what Elon Musk and the man in the White House, who may be the best name caller,… are going to do. But they sure don't seem like they're on great terms. So my plan is to have the president give Elon the right to have driverless cars on the interstate. I'm calling that plan shelved. But moral? There are usual ways to make a lot of money, but it's really fun to talk about Elon.' While we acknowledge the potential of TSLA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
